biophysics and biomedicine
AAO appeal decision on the EB-1A talent visa
Updated: Author: Alina Kanametova
This is a real, anonymized AAO appeal decision on the EB-1A immigrant visa, in the field of biophysics and biomedicine (Science), 2021. The appeal was appeal sustained, and on the final-merits determination the petitioner met the standard. Of the regulatory criteria, 5 were counted: Awards, Published material about you, Original contribution, Scholarly authorship, Commercial success; not counted: Leading role, Comparable evidence.
What this case shows
Bottom line: the appeal was sustained - a rare outcome in the appeals base. Of the 7 EB-1A criteria claimed, 5 were counted. The petitioner also passed the final-merits totality assessment - both the criteria and the overall extraordinary-ability standard.
EB-1A criteria in this case
- Awardscounted
- Membershipnot claimed
- Published material about youcounted
- Judgingnot claimed
- Original contributioncounted
- Scholarly authorshipcounted
- Exhibitionsnot claimed
- Leading rolenot counted
- High remunerationnot claimed
- Commercial successcounted
- Comparable evidencenot counted
Why these criteria usually go uncounted
The through-line of the appeals base: in 81% of decisions the AAO names the same problem - assertions not backed by sufficient evidence - and 45% of cases are lost at the final-merits totality assessment. Below is how each criterion not counted here fares across the whole base.
Leading role
Across the appeals base this criterion was argued in 624 cases and counted in 256 (41%). Counted when the organization is known and the role is leading or key, per the org chart and letters.
Comparable evidence
Across the appeals base this criterion was argued in 64 cases and counted in 1 (2%).
The Science field in the database: 155 appeals
Outcomes in this field: 7 sustained, 30 remanded, 118 dismissed. How the AAO ruled in this field on the criteria argued in this case:
| Criterion | In this case | Counted in the field | How objections were answered |
|---|---|---|---|
| Awards | counted | 4 of 54 (7%) | breakdowns for this criterion (7) |
| Published material about you | counted | 35 of 89 (39%) | breakdowns for this criterion (7) |
| Original contribution | counted | 33 of 123 (27%) | breakdowns for this criterion (7) |
| Scholarly authorship | counted | 121 of 127 (95%) | breakdowns for this criterion (6) |
| Leading role | not counted | 19 of 54 (35%) | breakdowns for this criterion (7) |
| Commercial success | counted | 1 of 2 (50%) | - |
| Comparable evidence | not counted | 0 of 7 (0%) | - |
Counted over our base of published AAO decisions; all Science appeals.
From the AAO decision (source, EN)
The initial denial was based on the petitioner not meeting any of the initial evidentiary criteria. The appeal was sustained after a court remanded the case, finding the petitioner met the criteria relating to awards, published materials, original contributions, and scholarly articles.
The quote summarizes a fragment of the decision; the table above reflects the FINAL status of the criteria across all stages of the case (including ones conceded before the appeal), so the wording may not match one-to-one.
Full AAO decision of August 27, 2021 (PDF, uscis.gov)AAO decisions archive on uscis.gov
FAQ on this case
- Which EB-1A criteria were counted in this case?
- Criteria claimed: 7, counted: 5 (Awards, Published material about you, Original contribution, Scholarly authorship, Commercial success); not counted: Leading role, Comparable evidence.
- How did this appeal end?
- The appeal was sustained - the denial was overturned in the petitioner's favor. A rare outcome: about 3% of our base.
- Did the case reach the final-merits stage?
- Yes, and on the totality assessment the petitioner met the extraordinary-ability standard.
The criteria not counted here - typical objections and how to respond:
Related
Similar appeals
- biophysics and biomedicineappeal dismissed, 2020
- Human Rights Law and Legal Researchappeal sustained, 2020
- Ocean Science/Marine Geologyappeal sustained, 2021
- Cardiovascular Researchappeal dismissed, 2020
- molecular biologyappeal dismissed, 2020
- Legal Science and Law (potentially Business)case remanded, 2024
- Pharmacyappeal dismissed, 2024